Passa al contenuto
Merck
Tutte le immagini(2)

Key Documents

View All Documentation

203629

Sigma-Aldrich

Lithium carbonate

99.997% trace metals basis

Sinonimo/i:

Carbolithium, Carbonic acid lithium salt

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(2)

About This Item

Formula condensata:
Li2CO3
Numero CAS:
554-13-2
Peso molecolare:
73.89
Beilstein:
3999191
Numero CE:
209-062-5
Numero MDL:
MFCD00011084
Codice UNSPSC:
12352302
eCl@ss:
38020204
ID PubChem:
24852186
NACRES:
NA.23

Livello qualitativo

100

Saggio

99.997% trace metals basis

Forma fisica

powder

Impurezze

≤35.0 ppm Trace Metal Analysis

Punto di fusione

618 °C (lit.)

Densità

2.11 g/mL at 25 °C

applicazioni

battery manufacturing

Stringa SMILE

[Li+].[Li+].[O-]C([O-])=O

InChI

1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2
XGZVUEUWXADBQD-UHFFFAOYSA-L

Informazioni sul gene

human ... GSK3A(2931) , GSK3B(2932) , IMPA1(3612)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302,H319

Classi di pericolo

Acute Tox. 4 Oral - Eye Irrit. 2

Codice della classe di stoccaggio

13 - Non Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 1

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Dispositivi di protezione individuale

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
MKCD1012
MKCD9781
MKCD6538
MKBV5437V
MKBR5246V

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 6

1 of 6

Lithium carbonate-13C 99 atom % 13C, 98% (CP)

Sigma-Aldrich

749427

Lithium carbonate-13C

Lithium-6Li2 carbonate 95 atom % 6Li

Sigma-Aldrich

473111

Lithium-6Li2 carbonate

Lithium carbonate EMPROVE® ESSENTIAL, Ph. Eur., BP, USP

SAFC

1.05671

Lithium carbonate

Lithium hydroxide monohydrate 99.995% trace metals basis

Sigma-Aldrich

450197

Lithium hydroxide monohydrate

Luxol® fast blue solution 1%

Sigma-Aldrich

L0294

Luxol® fast blue solution

Potassium carbonate ACS reagent, ≥99.0%

Sigma-Aldrich

209619

Potassium carbonate

K E Morrison et al.
The Lancet. Neurology, 12(4), 339-345 (2013-03-05)
Lithium has neuroprotective effects in cell and animal models of amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of lithium on survival. We aimed to assess whether lithium improves survival in
Robert L Findling et al.
Journal of child and adolescent psychopharmacology, 23(2), 80-90 (2013-03-21)
This study examined the long-term effectiveness of lithium for the treatment of pediatric bipolar disorder within the context of combination mood stabilizer therapy for refractory mania and pharmacological treatment of comorbid psychiatric conditions. Outpatients, ages 7-17 years, meeting American Psychiatric
Andrew A Nierenberg et al.
The American journal of psychiatry, 170(1), 102-110 (2013-01-05)
Lithium salts, once the mainstay of therapy for bipolar disorder, have tolerability issues at a higher dosage that often limit adherence. The authors investigated the comparative effectiveness of more tolerable dosages of lithium as part of optimized personalized treatment (OPT).
Harm-Pieter Spaans et al.
The Journal of clinical psychiatry, 74(11), e1029-e1036 (2013-12-18)
To compare the efficacy and cognitive side effects of high-dose unilateral brief pulse electroconvulsive therapy (ECT) with those of high-dose unilateral ultrabrief pulse ECT in the treatment of major depression. From April 2007 until March 2011, we conducted a prospective
Tom Bschor et al.
Journal of clinical psychopharmacology, 33(1), 38-44 (2013-01-02)
Studies of the 1970s and 1980s showed lithium monotherapy to be an effective treatment of acute unipolar major depressive disorder (MDD) and hence as a potential alternative to monoaminergic antidepressants.The objective was to conduct the first comparison of a lithium
Visualizza tutti i documenti correlati

Articoli

Lithium-Ion Battery Performance: Dependence on Material Synthesis and Post‑Treatment Methods

Lithium-Ion Battery Performance: Dependence on Material Synthesis and Post‑Treatment Methods

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.